Supplements for cognitive ability in patients with mild cognitive impairment or Alzheimers disease: a protocol for systematic review and network meta-analysis of randomised controlled trials

This study is scheduled to commence on 1 June 2023 and conclude on 1 October 2023.

Ethics and dissemination
Ethics approval is not required for systematic review and network meta-analysis. The results will be submitted to a peer-reviewed journal or at a conference.

Trial registration number
PROSPERO (CRD42023414700).

Source: BMJ Open - April 2, 2024 Category: General Medicine Authors: Zhang, X.-Y., Li, Y.-Q., Yin, Z.-H., Bao, Q.-N., Xia, M.-Z., Chen, Z.-H., Zhong, W.-Q., Wu, K.-X., Yao, J., Liang, F.-R. Tags: Open access, Neurology Source Type: research